Immunologic protection of rabbit corneal allografts: preparation and in vitro testing of heterologous 'blocking' antibody

Document Type

Article

Publication Date

12-1-1973

Abstract

Corneal allografts, like other foreign tissues, are subject to immunologic attack and rejection. Efforts to prolong graft survival have included the use of antilymphocyte serum and blocking antibodies. In this study antilymphocyte serum was tested as a potential corneal allograft blocking reagent. It has been demonstrated that guinea pig anti rabbit lymphocyte serum and the gamma globulin fraction of this serum bind to rabbit lymphocytes and corneal cells. In the presence of serum complement the antiserum and globulin are cytotoxic for cells of the cornea. Chemical modification of the anti lymphocyte globulin renders it incapable of complement fixation, creating a reagent which retains the capacity to bind to cells and, in addition, to protect them from the cytotoxic effects of unaltered antibody and serum complement. The benign and protective nature of modified antilymphocyte globulin suggests that it is an excellent candidate for use in the prevention of corneal graft rejection.

Publication Source (Journal or Book title)

Investigative Ophthalmology

First Page

646

Last Page

653

This document is currently not available here.

Share

COinS